NASDAQ:PBAX

Phoenix Biotech Acquisition - PBAX Stock Forecast, Price & News

Add

Today's Range: $10.07
▼
$10.07
50-Day Range: $10.01
▼
$10.07
52-Week Range: $9.71
▼
$11.76

Volume: 93,100 shs
Average Volume: 73,301 shs
Market Capitalization: $231.42 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Phoenix Biotech Acquisition

Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe. The company was incorporated in 2021 and is based in Oakland, California.

Phoenix Biotech Acquisition Stock Performance

Shares of NASDAQ:PBAX opened at $10.07 on Monday. The firm has a 50 day simple moving average of $10.03 and a 200 day simple moving average of $10.00. Phoenix Biotech Acquisition has a 52 week low of $9.71 and a 52 week high of $11.76.

Receive PBAX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Phoenix Biotech Acquisition and its competitors with MarketBeat's FREE daily newsletter.

PBAX Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

30 days | 90 days | 365 days | Advanced Chart

Receive PBAX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Phoenix Biotech Acquisition and its competitors with MarketBeat's FREE daily newsletter.

PBAX Company Calendar

Today: 8/08/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Holding & other investment offices
Sub-Industry: N/A
Sector: Unclassified
Current Symbol: NASDAQ:PBAX
CUSIP: N/A
CIK: 1870404
Web: N/A
Phone: 215-731-9450
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 22,981,000
Free Float: N/A
Market Cap: $231.42 million
Optionable: Not Optionable
Beta: N/A

Key Executives

Mr. Christopher B. Ehrlich M.B.A. (Age 52)
CEO & Director
Dr. Douglas Carl Fisher M.B.A (Age 46)
M.B.A., M.D., Pres
Mr. Daniel E. Geffken M.B.A. (Age 65)
MBA, Chief Financial Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

PBAX Stock - Frequently Asked Questions

How has Phoenix Biotech Acquisition's stock price performed in 2022?: Phoenix Biotech Acquisition's stock was trading at $9.91 at the beginning of the year. Since then, PBAX stock has increased by 1.6% and is now trading at $10.07.
View the best growth stocks for 2022 here.
Are investors shorting Phoenix Biotech Acquisition?: Phoenix Biotech Acquisition saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 5,200 shares, an increase of 188.9% from the June 30th total of 1,800 shares. Based on an average trading volume of 53,200 shares, the short-interest ratio is currently 0.1 days. Approximately 0.0% of the company's stock are sold short.
View Phoenix Biotech Acquisition's Short Interest.
What is Phoenix Biotech Acquisition's stock symbol?: Phoenix Biotech Acquisition trades on the NASDAQ under the ticker symbol "PBAX."

Who are Phoenix Biotech Acquisition's major shareholders?: Phoenix Biotech Acquisition's stock is owned by a number of institutional and retail investors. Top institutional investors include Wolverine Asset Management LLC (1.76%), Lynwood Capital Management Inc. (0.15%) and Robinson Capital Management LLC (0.03%).
How do I buy shares of Phoenix Biotech Acquisition?: Shares of PBAX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Phoenix Biotech Acquisition's stock price today?: One share of PBAX stock can currently be purchased for approximately $10.07.
How much money does Phoenix Biotech Acquisition make?: Phoenix Biotech Acquisition (NASDAQ:PBAX) has a market capitalization of $231.42 million.
How can I contact Phoenix Biotech Acquisition?: Phoenix Biotech Acquisition's mailing address is 2001 MARKET STREET SUITE 3400, PHILADELPHIA PA, 19103. The company can be reached via phone at 215-731-9450.

This page (NASDAQ:PBAX) was last updated on 8/8/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

MarketBeat Resources